Log in to your Inderes Free account to see all free content on this page.

Orexo

18.86 SEK

-0.32%

Less than 1K followers

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orexo

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)62.8050.0034.5018.8615.4617.5030.10
Shares34.634.634.334.434.434.534.7
Market cap2,174.21,731.11,184.5648.2532.6603.81,044.6
Enterprise value1,647.01,450.31,230.9836.0835.4956.5-
EV/S1.92.22.21.31.31.6-
EV/EBITDA6.176.3neg.neg.neg.40.9-
EV/EBIT7.1neg.neg.neg.neg.neg.-
P/E9.9neg.neg.neg.neg.neg.1.6
P/B3.083.103.393.349.04-4.782.13
P/S2.62.62.11.00.81.040.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio47.1 %45.3 %27.4 %17.5 %7.5 %-21.2 %37.7 %
Gearing ratio48.7 %48.7 %157.5 %278.3 %804.4 %-376.9 %100.2 %
Login required

This content is only available for logged in users